insomnia therapy (Scripps)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinsomnia therapy (Scripps)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor agonistsHydrolases inhibitors
TargetsSerotonin 2a (5-HT2a) receptorHydrolases
Therapy Area/IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A